Guardant Health (GH) 10-K2023 FY Annual report

Filed: 22 Feb 24, 5:23pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: al, alongside, analyst, APPI, channel, checkpoint, Circuit, contest, deruxtecan, endpoint, FD, fed, formalized, guarding, Head, hearing, jury, Korea, log, notable, overturn, password, percent, posture, prejudice, PSU, real, rulemaking, RYBREVANT, straightforward, surface, threat, trastuzumab, understood, verdict

Removed: absorb, acceleration, addressed, Aid, AIV, altered, amortizing, anniversary, approximate, arbitration, capitalizable, colon, commissioning, comprised, comprising, consolidate, construction, coupon, covenant, dataset, deconsolidation, economically, economy, eliminate, emergency, expert, featuring, forecast, formation, holding, installment, judgement, KeyGene, label, lacked, listed, measuring, nonemployee, nonstatutory, outbreak, par, post, prostate, ratably, recourse, reinvest, relaxed, remittance, requisition, retained, risky, run, separated, silico, SPLA, supplementary, suspended, temporarily, thereon, treated, unaudited, unissued, unremedied, version, weakened

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated GH transcripts

GH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Guardant Health, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Date:	February 22, 2024	/s/ AmirAli Talasaz
		AmirAli Talasaz
		Co-Chief Executive Officer and Director
		(Principal Executive Officer)

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.